BIOTEC
BIOTEC is Thailand's national biotechnology research institute under NSTDA, conducting platform-technology R&D in agriculture, biomedicine, and the environment and licensing proprietary diagnostics, crop varieties, enzymes, and controlled-environment systems to private-sector partners.
- Company typePrivate
- Founded1983
- HeadquartersBangkok, Thailand
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What BIOTEC does
BIOTEC (National Center for Genetic Engineering and Biotechnology) is a Thai government research institute established on 20 September 1983 and operated since 30 December 1991 as a center under the National Science and Technology Development Agency (NSTDA), functioning semi-autonomously outside the civil service framework. Headquartered at Thailand Science Park in Pathum Thani with approximately 570 staff (170 PhD researchers, 200 research assistants/technicians), BIOTEC conducts platform-technology R&D spanning agricultural biotechnology, biomedical science, and environmental science, with operating units also hosted at Thai universities.
The institute's technology portfolio comprises nucleic-acid diagnostic kits for shrimp pathogens (Ezee Gene: Nested PCR, Real-time PCR, LAMP Color), human diagnostics (i+LAB αTHAL thalassemia strip test, TB-DNAsensor Kit, LAMP-LFD malaria test, NS1 dengue ELISA), crop varieties (RD51 flood-tolerant jasmine rice, RD6 glutinous rice, AKG Tenera oil palm), feed enzymes (ENZboost, A-Zyme/Pentozyme), industrial enzymes (ENZease, ENZbleach), and the Plant Factory smart greenhouse system for controlled cultivation of medicinal herbs. Supporting infrastructure includes three subsidiaries — Thailand Bioresource Research Center (TBRC), National Omics Center (NOC), and National Biobank of Thailand (NBT) — plus BSL-2 laboratory and bioprocessing facilities.
BIOTEC's revenue model combines direct Thai government funding through NSTDA with commercial income from technology licensing to private companies (BioNet-Asia, i+MED Laboratories, Mobilis Automata, KEEEN, Asia Star Animal Health, Vicchi Enterprise, Peace Canning, PARWEL International, Drew-Bio, Eco Scientific, Sigma Aldrich), joint R&D contracts, fee-for-service technical work, and grants from international agencies (Medicines for Malaria Ventures, CSIRO, ARDA). Customers span aquaculture, agriculture, food, healthcare, and environmental sectors. Technology transfer is executed via licensing arrangements and partnerships through the NSTDA Technology Licensing Office; pricing for products and services is not publicly disclosed. GTM motions include direct industry consultation, joint research, technology licensing, and event-driven engagement through seminars and workshops such as InnoAgroindustry.
BIOTEC firmographics
Firmographics- Name
- BIOTEC
- Legal name
- National Center for Genetic Engineering and Biotechnology
- Website
- https://biotec.or.th
- Company type
- Private
- Founded year
- 1983
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- BIOTEC is Thailand's national biotechnology research institute under NSTDA, conducting platform-technology R&D in agriculture, biomedicine, and the environment and licensing proprietary diagnostics, crop varieties, enzymes, and controlled-environment systems to private-sector partners.
- Ownership category
- akta.pro rank
BIOTEC industry classification
Industry- Product category
- Biotechnology Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414), Medicinal and Botanical Manufacturing (325411), Pesticide and Other Agricultural Chemical Manufacturing (32532)
- SIC
- Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)
- akta.pro secondary industries
- Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF), Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES) (HLAAAJAE), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)
Keywords
Where BIOTEC is headquartered
LocationHeadquarters
- HQ city
- Bangkok
- HQ country
- Thailand
- HQ region
- Asia
Offices1 record
Markets served
BIOTEC business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Government Funding: Core funding from Thai government through NSTDA to support basic research, national biotechnology programs, and public-interest research initiatives.
- Commercialization and Services Revenue: Income from providing technical services, technology licensing, and commercializing research outputs to private sector and international funding agencies.
- Private Foundation and International Agency Funding: Revenue from non-government entities, international funding agencies, and private foundations for collaborative research projects.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
BIOTEC product offering
Product offeringCore offering
BIOTEC is Thailand's national biotechnology research institute operating under NSTDA, conducting applied R&D across agricultural science, biomedical science, and environmental science. It develops and commercializes proprietary diagnostic kits (LAMP/PCR-based for shrimp viruses, thalassemia, malaria, tuberculosis, dengue), crop varieties (rice, oil palm), industrial enzymes, biopesticides, fermented feed additives, wastewater treatment systems, and a smart Plant Factory platform, primarily through technology licensing to private companies, technical consulting, and direct sales via specialized laboratories.
Product overview
BIOTEC is Thailand's national research institute under NSTDA operating in biotechnology R&D. The organization offers a portfolio of diagnostic products (shrimp disease PCR/LAMP kits, human health tests for thalassemia/tuberculosis/malaria/dengue), agricultural biotechnology products (rice varieties, oil palm lines, biopesticides, feed enzymes, starter cultures), environmental technologies (biogas wastewater systems, bioremediation agents, denitrification reactors), and service platforms (FoodSERP for food innovation, Plant Factory for controlled-environment cultivation). Products are commercialized through licensing to private companies, technology transfer, and direct sales via specialized business units. The portfolio spans animal health, crop science, food technology, environmental management, and biomedical diagnostics.
Differentiator
Problem solved
Functional benefit
Products and services
- Shrimp Disease Diagnostic Tests
Quantifiable outcome
- Over 80% organic matter removal achieved by wastewater treatment systems
- +3 more outcomes
Companies that use BIOTEC
Customer profileNamed customers9 records
Segments5 records
Ideal customer profiles5 records
BIOTEC technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature8 records
BIOTEC partnerships and signals
Strategic signalPartnerships
23 partnerships are on record, tiered core, major and minor.
- National Science and Technology Development Agency (NSTDA)coreBIOTEC became one of NSTDA centers in 1991, operating outside normal civil service framework. NSTDA coordinates research funding activities and program management. Other NSTDA centers include MTEC, NECTEC, NANOTEC, and TMC.
- KEEEN LimitedmajorCollaboration on onsite microbial reactor for biological wastewater treatment. KEEEN manufactures the OMR reactor commercially. Also collaborated on bioremediation product development (KEEEN brand).
- Mobilis Automata Co., Ltd.majorLicensed Real-AMP LAMP-Turbidimeter technology for shrimp virus detection. Equipment marketed under Real-AMP brand, reagent as AMP Plus.
- Government Pharmaceutical Organization (GPO)majorPartner in Biologics and Pharmaceuticals Manufacturing in Thailand for Equitable Access to Medicines (BPM-TEAM) project with CSIRO and KMUTT.
- Commonwealth Scientific and Industrial Research Organisation (CSIRO)majorAustralia's national science agency. Partner in BPM-TEAM project to strengthen Thailand's pharmaceutical and biologics manufacturing capabilities.
- Pt.Bio Inc.minorJapanese company focused on food innovation through genome editing. Discussed potential collaborations on allergy-reduced eggs and food technology.
- Medicines for Malaria VenturesmajorNot-for-profit organization that selected P218 antimalarial drug candidate for further development. Supporting pre-clinical studies.
- i+MED Laboratories Company LimitedmajorLicensed immunochromatographic thalassemia detection technology. Product commercialized as i+LAB αTHAL.
- BioNet-Asia Co., Ltd.majorLicensed four serotypes of chimeric live-attenuated dengue vaccine candidate in February 2011 for commercial development.
- Embassy of JapanminorEconomic delegation visiting to discuss potential research collaborations in food innovation and genome editing.
- Australia's Chief ScientistminorHosted visit to strengthen Thailand-Australia research collaboration and explore national research infrastructure ecosystem.
- PARWEL INTERNATIONAL CO., LTD.majorLicensed IC strip test technology for detection of bacterial fruit blotch disease in cucurbits.
- Micro Innovate Co., Ltd.majorJoint investment over 100 million Baht between NSTDA, private company, and researchers for industrial-scale microbial production plant for animal feed. First of its kind in Thailand.
- Peace Canning Co., Ltd.majorLicensed starter culture technology for industrial production of pickled mustard greens including large-scale fermentation.
- Vicchi Enterprise Co., Ltd.majorLeading food ingredient company offering commercial starter cultures for fermented pork sausage (Nham) in liquid and powder forms.
- Asia Star Animal Health Co., Ltd.majorLicensed pentosanase enzyme technology. Products available as A-Zyme and Pentozyme feed additives.
- Eco Scientific Co., Ltd.majorLicensed portable dissolved oxygen test kit for commercialization.
- Drew-Bio (Thailand) Co., Ltd.majorLicensed thalassemia interpretation tool as added-on feature for Low Pressure Liquid Chromatography (LPLC) equipment.
- Srinakharinwirot UniversityminorCollaborated on TB-DNAsensor Kit development for tuberculosis diagnosis.
- Charoen Pokphand Foods PCLmajorImplemented hormone-based ovulation synchronization protocol for dairy cattle, along with dairy cooperatives and over 1,000 smallholder farmers.
- MK Farm (Chiang Mai)minorValidating disease-free orange production method through shoot-tip culture at farm in Fang District.
- Pak Hai Farmers CooperativeminorSuccessfully created business from Homcholasit rice production, selling branded 'On-waan' rice in supermarket chains.
- Sigma AldrichmajorLicensed three microorganisms (Xylaria spp., Verticillium spp., Lentinus spp.) for commercial production of depudecin, ascochlorin, and panepoxydone.
Scale indicators2 records
Recent moves7 records
Expansion highlights5 records
BIOTEC competitors and assessment
Company assessmentDirect peers
- A*STAR (Agency for Science, Technology and Research): Singapore's national R&D agency running biomedical, biotechnology, and platform technology programs with industry transfer. Highly comparable mandate to BIOTEC as a Southeast Asian government biotech research institute.
- CSIRO (Commonwealth Scientific and Industrial Research Organisation): Australia's national science agency and BIOTEC's direct BPM-TEAM partner. CSIRO performs applied biotech R&D with technology transfer to industry and operates national research infrastructure — a near-mirror of BIOTEC's mandate at larger scale.
Broad incumbents
- Fraunhofer Society: Germany's applied research network with a model of government-funded institutes conducting contract research and technology licensing to industry. Highly comparable applied-research-plus-tech-transfer model at much larger scale and broader scope.
- RIKEN: Japan's national research institute covering life sciences, computational biology, and bioengineering. Comparable as a government-funded multidisciplinary biotech research organization, though RIKEN is more focused on fundamental discovery than applied transfer.
Regional players
- Korea Research Institute of Bioscience and Biotechnology (KRIBB): South Korea's government bioscience and biotechnology research institute conducting applied R&D with industry partnerships. Highly comparable mandate and Asian government research model, though operating in a different national market.
- Indonesian Agency for Agricultural Research and Development (IAARD): Indonesia's government agricultural biotechnology research arm operating under the Ministry of Agriculture. Comparable in agricultural biotech focus and Southeast Asian government research model, though narrower in life sciences scope than BIOTEC.
- Siam Bioscience Co., Ltd. Thai biopharmaceutical contract manufacturer with strong government ties producing vaccines and biologics. Comparable as a Thai biotech industry counterpart that benefits from BIOTEC's upstream R&D and platform technology pipeline.
Others
- BioNet-Asia Co., Ltd. Thai vaccine manufacturer that licensed BIOTEC's dengue vaccine candidate in 2011. Comparable as a Thai biotech commercialization partner dependent on BIOTEC-derived technologies and serves as an example of BIOTEC's industry transfer pipeline.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
BIOTEC social profiles
Digital presenceBIOTEC financial estimates
Financial estimateRevenue estimate
Valuation estimate
BIOTEC leadership team
Management profileNumber of profiles
Profiles6 records
BIOTEC subsidiaries and ownership
Company hierarchySubsidiaries3 records
BIOTEC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BIOTEC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BIOTEC
What does BIOTEC do?
BIOTEC is Thailand's national biotechnology research institute operating under NSTDA, conducting applied R&D across agricultural science, biomedical science, and environmental science. It develops and commercializes proprietary diagnostic kits (LAMP/PCR-based for shrimp viruses, thalassemia, malaria, tuberculosis, dengue), crop varieties (rice, oil palm), industrial enzymes, biopesticides, fermented feed additives, wastewater treatment systems, and a smart Plant Factory platform, primarily through technology licensing to private companies, technical consulting, and direct sales via specialized laboratories.
Is BIOTEC a public or private company?
BIOTEC is a private company. It is classified as state government owned and is currently operating.
When was BIOTEC founded?
BIOTEC was founded in 1983. It employs 501 to 1,000 people.
Where is BIOTEC based?
BIOTEC is headquartered in Bangkok, Thailand, in the Asia region.
How does BIOTEC make money?
Three revenue lines are on record. Government Funding is the primary driver. The others are commercialization and Services Revenue and private Foundation and International Agency Funding.
Who are BIOTEC's main competitors?
Direct peers on record are A*STAR (Agency for Science, Technology and Research) and CSIRO (Commonwealth Scientific and Industrial Research Organisation). Broad incumbents are Fraunhofer Society and RIKEN. Regional players are Korea Research Institute of Bioscience and Biotechnology (KRIBB), Indonesian Agency for Agricultural Research and Development (IAARD) and Siam Bioscience Co., Ltd.. BioNet-Asia Co., Ltd. is listed as an others.
Does BIOTEC have an API?
No public API is recorded for BIOTEC.
What industry is BIOTEC in?
BIOTEC's product category is Biotechnology Research Services. Its primary akta.pro industry code is HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development), with a secondary code of HLAAAJAF, Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling). Its NAICS code is 541714 and its SIC code is 8731.